Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Origlia, Nicolaa; b | Capsoni, Simonab | Domenici, Lucianoa; c; d | Cattaneo, Antoninoe; *
Affiliations: [a] SISSA (International School for Advanced Studies), via Beirut 2–4, 34014 Trieste, Italy | [b] Lay Line Genomics SpA, 00128 Roma, Italy | [c] 3Institute of Neuroscience, CNR, 56127 Pisa, Italy | [d] Department of Biomedical Sciences and Technologies, L'Aquila University, 67010 L'Aquila | [e] Fondazione Rita Levi Montalcini-European Brain Research Institute, 00143 Roma, Italy
Correspondence: [*] Corresponding author: Prof.~Antonino Cattaneo, Fondazione Rita Levi-Montalcini- European Brain Research Institute, Via del Fosso di Fiorano 64, 00143 Roma, Italy. Tel.: +39 06 501703118; Fax: +39 06 50173302; E-mail: [email protected].
Abstract: A deficit in cortical cholinergic synaptic transmission is a common feature of cognitive and behavioral impairment observed in neurodegenerative pathologies. AD11 transgenic mice producing blocking antibodies against Nerve Growth Factor (NGF) are characterized by a progressive neurodegenerative phenotype defined by the deposition of amyloid peptide, intracellular neurofibrillary tangles and by a marked cholinergic depletion. We exploited AD11 mice to develop a functional assay to investigate the impact of cholinergic deficit on cortical synaptic plasticity impairment at different neurodegenerative stages. In particular, we investigated the time course of long–term potentiation (LTP) impairment in neocortex of AD11 mice and potential rescue by acute pharmacological treatment with Acetylcholine (ACh) or the cholinergic agonist Galantamine (GAL). We showed that LTP starts being absent in AD11 mice at 2 months, an age corresponding to early neurodegenerative stage characterized by the first observed decrease in number of basal forebrain cholinergic neurons (BFCNs) without overt cortical neurodegeneration. We demonstrated that acute ACh or GAL treatment fully reverts LTP impairment in 2 month old AD11 mice. In contrast, cholinergic treatment failed to recover synaptic plasticity deficit in aged (9–10 months) AD11 mice characterized by a severe cortical neurodegeneration.
Keywords: NGF deprivation, LTP, acetylcholine, galantamine, transgenic mice
DOI: 10.3233/JAD-2006-9106
Journal: Journal of Alzheimer's Disease, vol. 9, no. 1, pp. 59-68, 2006
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]